These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 32280041)
1. Success ofrotavirus vaccination in Finland, a register based study measuring impact beyond overall effectiveness. Solastie A; Leino T; Ollgren J Vaccine; 2020 May; 38(21):3766-3772. PubMed ID: 32280041 [TBL] [Abstract][Full Text] [Related]
2. Long-term surveillance of rotavirus vaccination after implementation of a national immunization program in Finland (2008-2018). Hemming-Harlo M; Gylling A; Herse F; Haavisto I; Nuutinen M; Pasternack M; Kanibir MN; Hartwig S; Carias C Vaccine; 2022 Jun; 40(29):3942-3947. PubMed ID: 35641360 [TBL] [Abstract][Full Text] [Related]
3. Effects of the rotavirus vaccine program across age groups in the United States: analysis of national claims data, 2001-2016. Baker JM; Dahl RM; Cubilo J; Parashar UD; Lopman BA BMC Infect Dis; 2019 Feb; 19(1):186. PubMed ID: 30795739 [TBL] [Abstract][Full Text] [Related]
4. First year experience of rotavirus immunisation programme in Finland. Leino T; Ollgren J; Salo H; Tiihonen P; Kilpi T Vaccine; 2012 Dec; 31(1):176-82. PubMed ID: 23122991 [TBL] [Abstract][Full Text] [Related]
5. Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan. Yoshikawa T; Matsuki T; Sato K; Mizuno M; Shibata M; Hasegawa S; Morita M; Iwasa M; Gopala K; Holl K Vaccine; 2018 Jan; 36(4):527-534. PubMed ID: 29248263 [TBL] [Abstract][Full Text] [Related]
6. Impact of five years of rotavirus vaccination in Finland - And the associated cost savings in secondary healthcare. Leino T; Baum U; Scott P; Ollgren J; Salo H Vaccine; 2017 Oct; 35(42):5611-5617. PubMed ID: 28893475 [TBL] [Abstract][Full Text] [Related]
7. Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland. Vesikari T; Uhari M; Renko M; Hemming M; Salminen M; Torcel-Pagnon L; Bricout H; Simondon F Pediatr Infect Dis J; 2013 Dec; 32(12):1365-73. PubMed ID: 24051998 [TBL] [Abstract][Full Text] [Related]
8. Effects of rotavirus vaccine on all-cause acute gastroenteritis and rotavirus hospitalizations in Israel: A nationwide analysis. Muhsen K; Haklai Z; Applbaum Y; Gordon ES; Shteiman A; Glatman-Freedman A; Leshem E Vaccine; 2020 Feb; 38(10):2406-2415. PubMed ID: 32029322 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status. Gosselin V; Généreux M; Gagneur A; Petit G Hum Vaccin Immunother; 2016 Oct; 12(10):2572-2579. PubMed ID: 27367155 [TBL] [Abstract][Full Text] [Related]
10. Direct and indirect impact on rotavirus positive and all-cause gastroenteritis hospitalisations in South Australian children following the introduction of rotavirus vaccination. Clarke MF; Davidson GP; Gold MS; Marshall HS Vaccine; 2011 Jun; 29(29-30):4663-7. PubMed ID: 21575665 [TBL] [Abstract][Full Text] [Related]
11. Rapid impact of rotavirus vaccine introduction to the National Immunization plan in southern Israel: comparison between 2 distinct populations. Givon-Lavi N; Ben-Shimol S; Cohen R; Greenberg D; Dagan R Vaccine; 2015 Apr; 33(16):1934-40. PubMed ID: 25744226 [TBL] [Abstract][Full Text] [Related]
13. Effectiveness of self-financed rotavirus vaccines on acute gastroenteritis primary care episodes using real-world data in Spain: a propensity score-matched analysis of cohort study. López-Lacort M; Muñoz-Quiles C; Díez-Domingo J; Orrico-Sánchez A Eur J Pediatr; 2024 Jul; 183(7):2843-2853. PubMed ID: 38584228 [TBL] [Abstract][Full Text] [Related]
14. Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland. Hemming M; Räsänen S; Huhti L; Paloniemi M; Salminen M; Vesikari T Eur J Pediatr; 2013 Jun; 172(6):739-46. PubMed ID: 23361964 [TBL] [Abstract][Full Text] [Related]
15. The economic impact of the introduction of universal rotavirus vaccination on rotavirus gastroenteritis related hospitalisations in children in Ireland. Murphy A; Kirby A; De Blasio F Vaccine; 2023 Apr; 41(16):2656-2663. PubMed ID: 36948981 [TBL] [Abstract][Full Text] [Related]
16. Impact of Routine Rotavirus Vaccination in Germany: Evaluation Five Years After Its Introduction. Marquis A; Koch J Pediatr Infect Dis J; 2020 Jul; 39(7):e109-e116. PubMed ID: 32187139 [TBL] [Abstract][Full Text] [Related]
17. Impact of the introduction of rotavirus vaccination on paediatric hospital admissions, Lothian, Scotland: a retrospective observational study. Forrest R; Jones L; Willocks L; Hardie A; Templeton K Arch Dis Child; 2017 Apr; 102(4):323-327. PubMed ID: 27806968 [TBL] [Abstract][Full Text] [Related]
18. Primary care-based surveillance to estimate the proportion of rotavirus gastroenteritis among Latvian children below 5 years of age with acute gastroenteritis. Tafalla M; Gardovska D; Gopala K; Kozlovska L Hum Vaccin Immunother; 2019; 15(6):1272-1278. PubMed ID: 30335570 [No Abstract] [Full Text] [Related]
19. Impact of rotavirus vaccine in reducing hospitalization rates in pediatric patients: a single center experience in Italy. Dettori S; Cortesia I; Mariani M; Opisso A; Mesini A; Saffioti C; Castagnola E Hum Vaccin Immunother; 2021 Dec; 17(12):5646-5649. PubMed ID: 34766869 [TBL] [Abstract][Full Text] [Related]
20. Rotavirus gastroenteritis hospitalizations in provinces with different vaccination coverage rates in Spain, 2013-2018. Ruiz-Contreras J; Alfayate-Miguelez S; Carazo-Gallego B; Onís E; Díaz-Munilla L; Mendizabal M; Méndez Hernández M; Ferrer-Lorente B; Unsaín-Mancisidor M; Ramos-Amador JT; Croche-Santander B; Centeno Malfaz F; Rodríguez-Suárez J; Cotarelo M; San-Martín M; Arístegui J BMC Infect Dis; 2021 Nov; 21(1):1138. PubMed ID: 34742235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]